9 nominees · 5 ballot items.
Elect nine directors; advisory approval of named executive officer compensation (say-on-pay); ratify Ernst & Young LLP as independent auditor; approve amendment to permit stockholder action by written consent; vote on a shareholder proposal to require an independent (non-CEO) board chair.
Elect nine director nominees named in the proxy statement to serve until the 2027 annual meeting.
Non-binding, advisory vote to approve the compensation of the named executive officers as disclosed in the proxy statement.
This advisory 'say-on-pay' proposal asks shareholders to approve, on a non-binding basis, the compensation paid to the company's named executive officers as disclosed in the proxy statement. Management and the Compensation Committee justify the program as pay-for-performance, with heavy weighting toward variable, performance-based incentives (SMIP, PSUs, RSUs) designed to align executives’ interests with long-term stockholder value and to attract and retain talent. The 2025 program emphasized non-GAAP operating income and strategic objectives for annual payouts and used adjusted free cash flow and adjusted EPS as the equally weighted metrics for three-year PSUs, with a 0–200% payout range to create stretch incentives. The Compensation Committee also revised the long-term incentive mix in 2025 (60% PSUs / 40% RSUs) and introduced a strategic objectives component to the SMIP to reward execution of the transformation plan. While the vote is advisory, the Board will consider the results when making future compensation decisions; historically the company has received strong support (approximately 91% approval in 2025). Key governance mitigants discussed by management include stock ownership guidelines, clawback provisions, double-trigger change-in-control vesting, and independent compensation consultant oversight. Risks for shareholders include concentrated CEO pay and the sensitivity of CAP and realized pay to stock price and PSU outcomes; management points to pay-versus-performance disclosures demonstrating alignment over time. The Board recommends a FOR vote because it believes the structure incentivizes long-term, sustainable value creation while providing appropriate retention and alignment features.
Ratify the Audit Committee’s selection of Ernst & Young LLP as the independent registered public accounting firm for 2026.
Approve an amendment to the Certificate of Incorporation to permit stockholders to take action by written consent in lieu of a meeting, subject to specified procedural safeguards and a 25% requesting-holder threshold.
This management proposal requests shareholder approval to amend the company’s Certificate of Incorporation to allow holders of Common Stock to act by written consent in lieu of a meeting, subject to carefully defined procedural conditions. The Board frames the change as a response to stockholder feedback (a 2025 stockholder proposal on written consent received ~51% support) and follow-up outreach to holders representing approximately 50% of outstanding shares, with the aim of expanding stockholder rights while embedding safeguards. Key elements of the proposed amendment include a 25% minimum requesting-holder ownership threshold to initiate the process, a requirement that requesting holders include the full text of proposed resolutions and disclosures, an obligation to solicit consents from all holders entitled to vote on the matter (ensuring broad notice), and several timing and content limitations to prevent disruptive or duplicative actions (e.g., blackout periods around annual meetings, restrictions where a similar item was recently presented). The Board retains the power to validate requests, set a record date within a 10‑day window, and decline requests that are invalid or improper; actions directed by the Board are exempt from these procedural conditions. From a governance perspective the amendment increases shareholder flexibility to act between meetings but introduces a non-trivial ownership threshold and solicitation obligations intended to reduce opportunistic or narrowly supported actions. The Board recommends FOR, arguing this balances enhanced shareholder engagement with fairness, transparency, and orderly corporate process. If approved, a conforming bylaw amendment will become effective and the company will file the Certificate of Amendment in Delaware.
A stockholder-submitted proposal requesting that the Board adopt a policy (and amend governing documents as necessary) to require that the roles of Chairman and CEO be held by separate people and that the Chairman be an independent director.
The shareholder proposal requests that the Board adopt a binding policy requiring separation of the Chair and CEO roles and that the Chair always be an independent director, arguing an independent chair would provide impartial oversight, strengthen accountability, and help address perceived weaknesses including relative stock underperformance and macro headwinds. The proponent frames the change as a governance improvement to mitigate conflicts of interest and increase shareholder confidence, and cites recent shareholder appetite for governance changes (e.g., a 51% vote supporting written-consent rights in 2025). Management’s counterargument emphasizes fiduciary duty and the need for the Board’s flexibility to choose the leadership structure best suited to the company’s circumstances; the Board highlights that a robust Lead Independent Director role, fully independent key committees, and other governance practices already provide independent oversight. Company-specific context: CDW currently combines the Chair and CEO roles (Christine Leahy is Chair and CEO) while maintaining a Lead Independent Director and majority-independent board, and the Board points to past transitions where it used both models. The dispute centers on governance trade-offs: proponents seek a fixed structural rule to guarantee independent chair oversight, while the Board argues a mandatory rule would be inflexible and could limit its ability to respond to strategy, succession, or market dynamics. For investors, the practical questions are whether a mandated independent chair would materially improve oversight and performance at CDW versus the existing arrangements and whether the benefits outweigh the loss of Board discretion; the Board’s recommendation against the proposal rests on preserving flexibility, pointing to prevailing market practice (only ~15% of S&P 500 require separation) and the Lead Independent Director’s substantive responsibilities. The Board therefore recommends voting AGAINST the proposal, arguing current structures and practices provide appropriate accountability while allowing adaptive governance.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6% | 8,420,409 | $1.0B |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.4% | 8,183,342 | $990M |
| 3 | STATE STREET CORP | 4.5% | 5,731,195 | $694M |
| 4 | HARRIS ASSOCIATES L P | 4.1% | 5,199,562 | $629M |
| 5 | BlackRock, Inc. | 3.6% | 4,542,968 | $550M |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 3,371,517 | $408M |
| 7 | BlackRock, Inc. | 2.4% | 3,041,255 | $368M |
| 8 | BlackRock, Inc. | 2.1% | 2,657,425 | $322M |
| 9 | Boston Partners | 2.1% | 2,636,014 | $319M |
| 10 | Allspring Global Investments Holdings, LLC | 2.0% | 2,503,334 | $304M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.